BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10434126)

  • 21. A novel RT-qPCR assay for quantification of the MLL-MLLT3 fusion transcript in acute myeloid leukaemia.
    Abildgaard L; Ommen HB; Lausen B; Hasle H; Nyvold CG
    Eur J Haematol; 2013 Nov; 91(5):394-8. PubMed ID: 23772754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
    Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
    Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic role of conventional cytogenetics and fluorescence in situ hybridization (FISH) in chronic myeloid leukemia patients.
    Jha CB; Kucheria K; Choudhary VP
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):171-5. PubMed ID: 18603893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular genetics in chronic myeloid leukemia with variant Ph translocation].
    Wu W; Li JY; Zhu Y; Qiu HR; Pan JL; Xu W; Chen LJ; Shen YF; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):470-3. PubMed ID: 17680547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABL1 amplification in T-cell acute lymphoblastic leukemia.
    Bernasconi P; Calatroni S; Giardini I; Inzoli A; Castagnola C; Cavigliano PM; Rocca B; Boni M; Quarna J; Zappatore R; Caresana M; Bianchessi C; Pallavicini EB; Lazzarino M
    Cancer Genet Cytogenet; 2005 Oct; 162(2):146-50. PubMed ID: 16213363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute myeloid leukemia (AML-M2) with t(5;11)(q35;q13) and normal expression of cyclin D1.
    de Oliveira FM; Tone LG; Simões BP; Falcão RP; Brassesco MS; Sakamoto-Hojo ET; dos Santos GA; Marinato AF; Jácomo RH; Rego EM
    Cancer Genet Cytogenet; 2007 Jan; 172(2):154-7. PubMed ID: 17213025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MLL rearrangements in acute leukemias].
    Urioste M; Arranz E; Martínez-Delgado B; Soto C; Román A; Pérez I; Mayayo M; Pérez-Pons C; Barroso A; Benítez J
    Sangre (Barc); 1999 Dec; 44(6):464-8. PubMed ID: 10822761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An acute myeloid leukemia case with concurrent 11q23 anomaly and D13S319 deficiency diagnosed by combined inter- and metaphase fluorescence in situ hybridization].
    Zhang Z; Wang Y; Wan W; Ke X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Jan; 37(1):48-51. PubMed ID: 31922596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region.
    Maravelaki S; Burford A; Wotherspoon A; Joshi R; Matutes E; Catovsky D; Brito-Babapulle V
    Cancer Genet Cytogenet; 2004 Oct; 154(1):67-71. PubMed ID: 15381376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An interstitial 11q23 deletion proven to be a rearrangement interrupting the MLL gene in an infant with acute myeloblastic leukemia.
    Leblanc T; Le Coniat M; Flexor M; Baruchel A; Daniel MT; Berger R
    Leukemia; 1996 Nov; 10(11):1844-6. PubMed ID: 8892693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: sequential cytogenetic and molecular analyses.
    Nawata R; Shinohara K; Yamada T; Takahashi T; Katsuki K; Takeda K; Kameda N; Ariyoshi K; Ota I; Muraki K
    Int J Hematol; 2000 Jun; 71(4):353-8. PubMed ID: 10905055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FISH monitoring of 100 courses of human leukemias: the cytogenetic viewpoint.
    Gebhart E; Rösler W; Gramatzki M; Trautmann U
    Int J Oncol; 2001 Sep; 19(3):617-23. PubMed ID: 11494045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-way translocation of MLL/MLLT3, t(1;9;11)(p34.2;p22;q23), in a pediatric case of acute myeloid leukemia.
    Jun KR; Lee JN; Park JA; Kim HR; Shin JH; Oh SH; Lee JY; Song SA
    Korean J Lab Med; 2011 Apr; 31(2):127-9. PubMed ID: 21474990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interphase fluorescence in situ hybridization analysis: a study using centromeric probes 7, 8, and 12.
    Zhao L; Khan Z; Hayes KJ; Glassman AB
    Ann Clin Lab Sci; 1998; 28(1):51-6. PubMed ID: 9512785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interphase cytogenetics of the t(8;21)(q22;q22) associated with acute myelogenous leukemia by two-color fluorescence in situ hybridization.
    Sacchi N; Magnani I; Kearney L; Wijsman J; Hagemeijer A; Darfler M
    Cancer Genet Cytogenet; 1995 Feb; 79(2):97-103. PubMed ID: 7889521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic yield of bone marrow and peripheral blood FISH panel testing in clinically suspected myelodysplastic syndromes and/or acute myeloid leukemia: a prospective analysis of 433 cases.
    Coleman JF; Theil KS; Tubbs RR; Cook JR
    Am J Clin Pathol; 2011 Jun; 135(6):915-20. PubMed ID: 21571964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between interphase and metaphase cytogenetics in detecting chromosome 7 defects in hematological neoplasias.
    Zhao L; van Oort J; Cork A; Liang JC
    Am J Hematol; 1993 Jul; 43(3):205-11. PubMed ID: 8352237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia.
    Fischer K; Scholl C; Sàlat J; Fröhling S; Schlenk R; Bentz M; Stilgenbauer S; Lichter P; Döhner H
    Blood; 1996 Nov; 88(10):3962-71. PubMed ID: 8916963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of five dual-color, double-fusion fluorescence in situ hybridization assays for the detection of common MLL translocation partners.
    Keefe JG; Sukov WR; Knudson RA; Nguyen LP; Williamson C; Sinnwell JP; Ketterling RP
    J Mol Diagn; 2010 Jul; 12(4):441-52. PubMed ID: 20539022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction.
    Mitterbauer G; Zimmer C; Pirc-Danoewinata H; Haas OA; Hojas S; Schwarzinger I; Greinix H; Jäger U; Lechner K; Mannhalter C
    Br J Haematol; 2000 Jun; 109(3):622-8. PubMed ID: 10886213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.